Mycoplasma genitalium infection is associated with microscopic signs of cervical inflammation in liquid cytology specimens

Journal of Clinical Microbiology

Volumn 52, Issue 7, 2014, Pages 2398-2405

  Dehon, Patricia M ^a   McGowin, Chris L ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CELL INFILTRATION; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE SEQUENCE; GONORRHEA; HIGH RISK PATIENT; HOSPITAL INFORMATION SYSTEM; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MICROSCOPY; MYCOPLASMA GENITALIUM INFECTION; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; TRICHOMONIASIS; UTERINE CERVICITIS; UTERINE CERVIX CYTOLOGY; CASE CONTROL STUDY; CHLAMYDIA INFECTIONS; CLASSIFICATION; CYTOLOGY; DNA SEQUENCE; DRUG EFFECTS; GENETICS; GENOTYPE; INFLAMMATION; ISOLATION AND PURIFICATION; LEUKOCYTE COUNT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR GENETICS; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; TRICHOMONAS INFECTIONS; UNITED STATES; UTERINE CERVIX; YOUNG ADULT;

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BIOMARKERS; CASE-CONTROL STUDIES; CERVIX UTERI; CHLAMYDIA INFECTIONS; CYTOLOGICAL TECHNIQUES; FEMALE; GENOTYPE; GONORRHEA; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LOUISIANA; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; TRICHOMONAS INFECTIONS; UTERINE CERVICITIS; YOUNG ADULT;

EID: 84903789100     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00159-14     Document Type: Article

References (56)

1. Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC. 2009. Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex. Transm. Dis. 36:598-606. http://dx.doi.org/10.1097/OLQ.0b013e3181b01948.
2. Brunham RC, Paavonen J, Stevens CE, Kiviat N, Kuo CC, Critchlow CW, Holmes KK. 1984. Mucopurulent cervicitis-the ignored counterpart in women of urethritis in men. N. Engl. J. Med. 311:1-6. http://dx.doi.org/10.1056/ NEJM198407053110101.
3. Workowski KA, Berman S. 2010. Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb. Mortal. Wkly. Rep. 59:1-110.
4. Paavonen J, Wolner-Hanssen P. 1986. Chlamydia infection and infertility. Lakartidningen 83:2916-2917.
5. Holmes KK. 1999. Sexually transmitted diseases, 3rd ed. McGraw-Hill Press, New York, NY.
6. Marrazzo JM, Martin DH. 2007. Management of women with cervicitis. Clin. Infect. Dis. 44(Suppl 3):S102-S110. http://dx.doi.org/10.1086/511423.
7. Ryan CA, Courtois BN, Hawes SE, Stevens CE, Eschenbach DA, Holmes KK. 1998. Risk assessment, symptoms, and signs as predictors of vulvovaginal and cervical infections in an urban US STD clinic: implications for use of STD algorithms. Sex. Transm. Infect. 74(Suppl 1):S59-S76.
8. Tyndall MW, Kidula N, Sande J, Ombette J, Temmerman M. 1999. Predicting Neisseria gonorrhoeae and Chlamydia trachomatis infection using risk scores, physical examination, microscopy, and leukocyte esterase urine dipsticks among asymptomatic women attending a family planning clinic in Kenya. Sex. Transm. Dis. 26:476-482. http://dx.doi.org/10.1097/00007435-199909000-00010.
9. Marrazzo JM, Handsfield HH, Whittington WL. 2002. Predicting chlamydial and gonococcal cervical infection: implications for management of cervicitis. Obstet. Gynecol. 100:579-584. http://dx.doi.org/10.1016/S0029-7844 (02)02140-3.
10. Oliphant J, Azariah S. 2013. Cervicitis: limited clinical utility for the detection of Mycoplasma genitalium in a cross-sectional study of women attending a New Zealand sexual health clinic. Sex. Health 10:263-267. http://dx.doi.org/10.1071/SH12168.
11. McGowin CL, Anderson-Smits C. 2011. Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women. PLoS Pathog. 7:e1001324. http://dx.doi.org/10.1371/journal.ppat.1001324.
12. Taylor-Robinson D, Jensen JS. 2011. Mycoplasma genitalium: from chrysalis to multicolored butterfly. Clin. Microbiol. Rev. 24:498-514. http://dx.doi.org/10.1128/CMR.00006-11.
13. Bradshaw CS, Chen MY, Fairley CK. 2008. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One 3:e3618. http://dx.doi.org/10.1371/journal.pone.0003618.
14. Cohen CR, Nosek M, Meier A, Astete SG, Iverson-Cabral S, Mugo NR, Totten PA. 2007. Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex. Transm. Dis. 34:274-279. http://dx.doi.org/10.1097/01.olq.0000237860.61298.54.
15. Hjorth SV, Bjornelius E, Lidbrink P, Falk L, Dohn B, Berthelsen L, Ma L, Martin DH, Jensen JS. 2006. Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J. Clin. Microbiol. 44:2078-2083. http://dx.doi.org/10.1128/JCM.00003-06.
16. Iverson-Cabral SL, Astete SG, Cohen CR, Rocha EP, Totten PA. 2006. Intrastrain heterogeneity of the mgpB gene in Mycoplasma genitalium is extensive in vitro and in vivo and suggests that variation is generated via recombination with repetitive chromosomal sequences. Infect. Immun. 74:3715-3726. http://dx.doi.org/10.1128/IAI.00239-06.
17. Baseman JB, Cagle M, Korte JE, Herrera C, Rasmussen WG, Baseman JG, Shain R, Piper JM. 2004. Diagnostic assessment of Mycoplasma genitalium in culture-positive women. J. Clin. Microbiol. 42:203-211. http://dx.doi.org/10. 1128/JCM.42.1.203-211.2004.
18. Clausen HF, Fedder J, Drasbek M, Nielsen PK, Toft B, Ingerslev HJ, Birkelund S, Christiansen G. 2001. Serological investigation of Mycoplasma genitalium in infertile women. Hum. Reprod. 16:1866-1874. http://dx.doi.org/10. 1093/humrep/16.9.1866.
19. Furr PM, Taylor-Robinson D. 1984. Microimmunofluorescence technique for detection of antibody to Mycoplasma genitalium. J. Clin. Pathol. 37:1072-1074. http://dx.doi.org/10.1136/jcp.37.9.1072.
20. Iverson-Cabral SL, Manhart LE, Totten PA. 2011. Detection of Mycoplasma genitalium-reactive cervicovaginal antibodies among infected women. Clin. Vaccine Immunol. 18:1783-1786. http://dx.doi.org/10.1128/CVI.05174-11.
21. McGowin CL, Spagnuolo RA, Pyles RB. 2010. Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation. Infect. Immun. 78:726-736. http://dx.doi.org/10.1128/IAI. 00840-09.
22. Muller BR, Taylor-Robinson D, Furr PM, Freundt EA. 1985. Acute upper genital-tract disease in female monkeys provoked experimentally by Mycoplasma genitalium. Br. J. Exp. Pathol. 66:417-426.
23. Svenstrup HF, Fedder J, Kristoffersen SE, Trolle B, Birkelund S, Christiansen G. 2008. Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility-a prospective study. Fertil. Steril. 90:513-520. http://dx.doi.org/10.1016/j.fertnstert.2006.12.056.
24. Svenstrup HF, Jensen JS, Gevaert K, Birkelund S, Christiansen G. 2006. Identification and characterization of immunogenic proteins of Mycoplasma genitalium. Clin. Vaccine Immunol. 13:913-922. http://dx.doi.org/10.1128/CVI. 00048-06.
25. Taylor-Robinson D, Furr PM, Hanna NF. 1985. Microbiological and serological study of non-gonococcal urethritis with special reference to Mycoplasma genitalium. Genitourin. Med. 61:319-324.
26. Taylor-Robinson D, Furr PM, Tully JG, Barile MF, Moller BR. 1987. Animal models of Mycoplasma genitalium urogenital infection. Isr. J. Med. Sci. 23:561-564.
27. Tully JG, Taylor-Robinson D, Rose DL, Furr PM, Graham CE, Barile MF. 1986. Urogenital challenge of primate species with Mycoplasma genitalium and characteristics of infection induced in chimpanzees. J. Infect. Dis. 153:1046-1054. http://dx.doi.org/10.1093/infdis/153.6.1046.
28. Manhart LE. 2013. Mycoplasma genitalium: an emergent sexually transmitted disease? Infect. Dis. Clin. North Am. 27:779-792. http://dx.doi.org/10.1016/j. idc.2013.08.003.
29. Massad LS. 2012. New guidelines on cervical cancer screening: more than just the end of annual Pap testing. J. Low. Genit. Tract Dis. 16:172-174. http://dx.doi.org/10.1097/LGT.0b013e31824bc178.
30. McGowin CL, Annan RS, Quayle AJ, Greene SJ, Ma L, Mancuso MM, Adegboye D, Martin DH. 2012. Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infect. Immun. 80:3842-3849. http://dx.doi.org/10.1128/IAI.00819-12.
31. Jalal H, Stephen H, Curran MD, Burton J, Bradley M, Carne C. 2006. Development and validation of a rotor-gene real-time PCR assay for detection, identification, and quantification of Chlamydia trachomatis in a single reaction. J. Clin. Microbiol. 44:206-213. http://dx.doi.org/10.1128/JCM.44.1. 206-213.2006.
32. Hjelmevoll SO, Olsen ME, Sollid JU, Haaheim H, Unemo M, Skogen V. 2006. A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene. J. Mol. Diagn. 8:574-581. http://dx.doi.org/10.2353/jmoldx.2006.060024.
33. Jensen JS, Uldum SA, Sondergard-Andersen J, Vuust J, Lind K. 1991. Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples. J. Clin. Microbiol. 29:46-50.
34. Jensen JS. 2012. Protocol for the detection of Mycoplasma genitalium by PCR from clinical specimens and subsequent detection of macrolide resistance-mediating mutations in region V of the 23S rRNA gene. Methods Mol. Biol. 903:129-139. http://dx.doi.org/10.1007/978-1-61779-937-2-8.
35. Anagrius C, Lore B, Jensen JS. 2013. Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic. PLoS One 8:e61481. http://dx.doi.org/10. 1371/journal.pone.0061481.
36. Chrisment D, Charron A, Cazanave C, Pereyre S, Bebear C. 2012. Detection of macrolide resistance in Mycoplasma genitalium in France. J. Antimicrob. Chemother. 67:2598-2601. http://dx.doi.org/10.1093/jac/dks263.
37. Ito S, Shimada Y, Yamaguchi Y, Yasuda M, Yokoi S, Nakano M, Ishiko H, Deguchi T. 2011. Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. Sex. Transm. Infect. 87:412-414. http://dx.doi.org/10.1136/ sextrans-2011-050035.
38. Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. 2008. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin. Infect. Dis. 47:1546-1553. http://dx.doi.org/10.1086/593188.
39. Shimada Y, Deguchi T, Nakane K, Yasuda M, Yokoi S, Ito S, Nakano M, Ishiko H. 2011. Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan. Emerg. Infect. Dis. 17:1148-1150. http://dx.doi.org/10.3201/ eid1706.101055.
40. Twin J, Jensen JS, Bradshaw CS, Garland SM, Fairley CK, Min LY, Tabrizi SN. 2012. Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis. PLoS One 7:e35593. http://dx.doi.org/10.1371/journal.pone .0035593.
41. Walker J, Fairley CK, Bradshaw CS, Tabrizi SN, Twin J, Chen MY, Taylor N, Donovan B, Kaldor JM, McNamee K, Urban E, Walker S, Currie M, Birden H, Bowden FJ, Gunn J, Pirotta M, Gurrin L, Harindra V, Garland SM, Hocking JS. 2013. Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. Clin. Infect. Dis. 56:1094-1100. http://dx.doi.org/10.1093/cid/cis1210.
42. Yew HS, Anderson T, Coughlan E, Werno A. 2011. Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritis. J. Clin. Microbiol. 49:1695-1696. http://dx.doi.org/ 10.1128/JCM.02475-10.
43. Manhart LE, Holmes KK, Hughes JP, Houston LS, Totten PA. 2007. Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am. J. Public Health 97:1118-1125. http://dx.doi.org/10. 2105/AJPH.2005.074062.
44. Falk L. 2010. The overall agreement of proposed definitions of mucopurulent cervicitis in women at high risk of Chlamydia infection. Acta Derm. Venereol. 90:506-511. http://dx.doi.org/10.2340/00015555-0924.
45. Lillis RA, Nsuami MJ, Myers L, Martin DH. 2011. Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women. J. Clin. Microbiol. 49:1990-1992. http://dx.doi.org/10.1128/JCM.00129- 11.
46. Mobley VL, Hobbs MM, Lau K, Weinbaum BS, Getman DK, Sena AC. 2012. Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors. Sex. Transm. Dis. 39:706-709. http://dx.doi.org/10.1097/OLQ.0b013e318255de03.
47. Manhart LE, Gillespie CW, Lowens MS, Khosropour CM, Colombara DV, Golden MR, Hakhu NR, Thomas KK, Hughes JP, Jensen NL, Totten PA. 2013. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin. Infect. Dis. 56:934-942. http://dx.doi.org/10.1093/cid/cis1022.
48. Mena LA, Mroczkowski TF, Nsuami M, Martin DH. 2009. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin. Infect. Dis. 48: 1649-1654. http://dx.doi.org/10.1086/599033.
49. Schwebke JR, Rompalo A, Taylor S, Sena AC, Martin DH, Lopez LM, Lensing S, Lee JY. 2011. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens-a randomized clinical trial. Clin. Infect. Dis. 52:163-170. http://dx.doi.org/10.1093/cid/ciq074.
50. Couldwell DL, Tagg KA, Jeoffreys NJ, Gilbert GL. 2013. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int. J. STD AIDS 24:822-828. http://dx.doi.org/10. 1177/0956462413502008.
51. Coleman JS, Hitti J, Bukusi EA, Mwachari C, Muliro A, Nguti R, Gausman R, Jensen S, Patton D, Lockhart D, Coombs R, Cohen CR. 2007. Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 21:755-759. http://dx.doi.org/10.1097/QAD .0b013e328012b838.
52. Johnson LF, Lewis DA. 2008. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex. Transm. Dis. 35:946-959. http://dx.doi.org/10.1097/OLQ.0b013e3181812d15.
53. McClelland RS, Wang CC, Mandaliya K, Overbaugh J, Reiner MT, Panteleeff DD, Lavreys L, Ndinya-Achola J, Bwayo JJ, Kreiss JK. 2001. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 15:105-110. http://dx.doi.org/10.1097/00002030-200101050-00015.
54. Mavedzenge SN, Van Der Pol B, Weiss HA, Kwok C, Mambo F, Chipato T, Van der Straten A, Salata R, Morrison C. 2012. The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS 26: 617-624. http://dx.doi.org/10.1097/QAD.0b013e32834ff690.
55. Vandepitte J, Weiss HA, Bukenya J, Nakubulwa S, Mayanja Y, Matovu G, Kyakuwa N, Hughes P, Hayes R, Grosskurth H. 2013. Alcohol use, Mycoplasma genitalium, and other STIs associated With HIV incidence among women at high risk in Kampala, Uganda. J. Acquir. Immune Defic. Syndr. 62:119-126. http://dx.doi.org/10.1097/QAI.0b013e3182777167.
56. Napierala Mavedzenge S, Weiss HA. 2009. Association of Mycoplasma genitalium and HIV infection: a systematic review and meta-analysis. AIDS 23:611-620. http://dx.doi.org/10.1097/QAD.0b013e328323da3e.